...
首页> 外文期刊>Endocrine journal >A Patient with Preclinical Cushing's Syndrome and Excessive DHEA-S Secretion Having Unilateral Adrenal Carcinoma and Contralateral Adenoma
【24h】

A Patient with Preclinical Cushing's Syndrome and Excessive DHEA-S Secretion Having Unilateral Adrenal Carcinoma and Contralateral Adenoma

机译:临床前库欣综合征和DHEA-S分泌过多的单侧肾上腺癌和对侧腺瘤患者

获取原文
           

摘要

References(21) Cited-By(6) We report a case of preclinical Cushing's syndrome in a 54-year-old male associated with bilateral adrenocortical tumours. Physical findings and general laboratory data were unremarkable except for mild hypertension (158/90mmHg) and impaired glucose tolerance. Endocrinological evaluation revealed the presence of autonomous cortisol secretion including unsuppressible serum cortisol by 8 mg dexamethasone test (11μg/dl), high serum DHEA-S (3580ng/ml, normal: 400-3500) and increased urinary 17-KS excretion (31.0-35.8mg/day, normal: 5.8-21.3). CT scan demonstrated the presence of tumours in both adrenals and bilateral adrenalectomy was subsequently performed. Histological examination of the resected specimens revealed an adrenocortical carcinoma on the right side and an adenoma on the left side with noticeable cortical atrophy in non-neoplastic adrenals. Immunohistochemical study of steroidogenic enzymes demonstrated that all the steroidogenic enzymes involved in cortisol biosynthesis were expressed in both right and left adrenal tumours. Enzymatic activities of 21, 17α, 18, 11β-hydroxylases were detected in both right and left adrenals except for the absence of 11β-hydroxylase activity in the left adrenal adenoma. Results of in vitro tissue steroidogenesis examined in short-term tissue culture of the specimens revealed no significant differences between carcinoma and adenoma in cortisol production, but the production of adrenal androgens in carcinoma was significantly higher than that in adenoma, which may indicate the importance of evaluating adrenal androgen levels in patients with adrenocortical neoplasms.
机译:参考文献(21)被引用者(6)我们报道了一位54岁的男性与双侧肾上腺皮质肿瘤相关的临床前库欣综合症病例。除轻度高血压(158 / 90mmHg)和糖耐量减低外,身体检查和一般实验室数据均无异常。内分泌学评估显示存在自主分泌的皮质醇,包括8 mg地塞米松试验(11μg/ dl)不能抑制的血清皮质醇,高血清DHEA-S(3580ng / ml,正常值:400-3500)和尿中17-KS排泄增加(31.0 35.8mg /天,正常:5.8-21.3)。 CT扫描显示肾上腺均存在肿瘤,随后进行双侧肾上腺切除术。切除标本的组织学检查显示,右侧为肾上腺皮质癌,左侧为腺瘤,非肿瘤性肾上腺有明显的皮质萎缩。对类固醇生成酶的免疫组织化学研究表明,参与皮质醇生物合成的所有类固醇生成酶均在左右肾上腺肿瘤中表达。除了左肾上腺腺瘤中不存在11β-羟化酶活性外,在右肾和左肾上腺中均检测到21、17α,18、11β-羟化酶的酶活性。在标本的短期组织培养中检测的体外组织类固醇生成的结果显示,癌和腺瘤之间皮质醇的产生没有显着差异,但是癌中肾上腺雄激素的产生显着高于腺瘤,这表明评估肾上腺皮质肿瘤患者的肾上腺雄激素水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号